Biotech IPO raising in Q1 2024 surged from Q4 2023 – but has the momentum lasted?
Biotech initial public offerings (IPOs) surged in Q1 2024, with eight completed IPOs raising a total of $3.72bn, six times more than the $621m raised in Q4 2023. This resulted in Q1 2024 having a higher biotech IPO value raised than any quarter in 2023, …